Trial Profile
Phase 2 trial of pyridoxamine in patients with type 1 and 2 diabetes and overt diabetic nephropathy (PYR-205)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pyridoxamine (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- Sponsors BioStratum
- 05 Nov 2010 New trial record.